A comparative study of four methods for detecting fibrinogen degradation products in patients with various diseases.
D000328:Adult; D000372:Agglutination Tests; D001172:Arthritis, Rheumatoid / Q000097:blood; D001777:Blood Coagulation / Q000187:drug effects; D001778:Blood Coagulation Disorders / Q000175:diagnosis*; D001779:Blood Coagulation Factors / Q000032:analysis; D001780:Blood Coagulation Tests; D003276:Contraceptives, Oral / Q000494:pharmacology; D004912:Erythrocytes; D005188:False Negative Reactions; D005189:False Positive Reactions; D005260:Female; D005337:Fibrin / Q000378:metabolism; D005340:Fibrinogen / Q000378:metabolism*; D005341:Fibrinolysin / Q000032:analysis; D005342:Fibrinolysis; D006385:Hemagglutination Inhibition Tests; D006689:Hodgkin Disease / Q000097:blood; D006801:Humans; D007118:Immunoassay; D005779:Immunodiffusion; D007674:Kidney Diseases / Q000097:blood; D008103:Liver Cirrhosis / Q000097:blood; D008228:Lymphoma, Non-Hodgkin / Q000097:blood; D008297:Male; D008722:Methods; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood; D009369:Neoplasms / Q000097:blood; D010958:Plasminogen / Q000032:analysis; D013210:Staphylococcus
D001779:Blood Coagulation Factors; D003276:Contraceptives, Oral; D005337:Fibrin; D005340:Fibrinogen; D010958:Plasminogen; D005341:Fibrinolysin